News

Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...
Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...
Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a ...
Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...